[company_age]19.0[/company_age][employees]501-1000 employees[/employees][funding]series_b[/funding][description]Cyagen Biosciences is a leading provider of custom cell line models, stem cell products, and discovery & preclinical CRO services. The company specializes in the development of humanized mouse models, which are used to study human diseases and develop new therapies. Cyagen's humanized mouse models are created using a proprietary technology that allows for the engraftment of human immune cells into mice. This technology allows researchers to study human diseases in a more accurate and relevant model system. In addition to humanized mouse models, Cyagen also offers a wide range of other custom cell line models, including induced pluripotent stem cells (iPSCs), knockin cell lines, knockout cell lines, point mutation cell lines, and overexpression cell lines. Cyagen's stem cell products include a variety of stem cells, cell media, and cell supplements. The company's discovery & preclinical CRO services include a variety of services, such as antibody development, phenotype analysis and evaluation, and CRO services for immune cell therapy. Cyagen is a global company with operations in the United States, China, and Europe. The company has a strong track record of innovation and is committed to providing its customers with the highest quality products and services.[/description][ps]Custom cell line models, stem cell products, discovery & preclinical CRO services[/ps]